nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—BMPR2—artery—intracranial aneurysm	0.0172	0.0352	CbGeAlD
Ruxolitinib—RPS6KA6—brainstem—intracranial aneurysm	0.0137	0.028	CbGeAlD
Ruxolitinib—PHKG2—brainstem—intracranial aneurysm	0.0085	0.0174	CbGeAlD
Ruxolitinib—HIPK2—brainstem—intracranial aneurysm	0.00818	0.0167	CbGeAlD
Ruxolitinib—CAMK1—medulla oblongata—intracranial aneurysm	0.00745	0.0152	CbGeAlD
Ruxolitinib—DYRK1A—brainstem—intracranial aneurysm	0.00736	0.0151	CbGeAlD
Ruxolitinib—BMPR2—brainstem—intracranial aneurysm	0.00733	0.015	CbGeAlD
Ruxolitinib—PRKCE—cerebellum—intracranial aneurysm	0.00702	0.0144	CbGeAlD
Ruxolitinib—MAST1—cerebellum—intracranial aneurysm	0.00675	0.0138	CbGeAlD
Ruxolitinib—RPS6KA6—cerebellum—intracranial aneurysm	0.00675	0.0138	CbGeAlD
Ruxolitinib—CAMK2G—brainstem—intracranial aneurysm	0.00656	0.0134	CbGeAlD
Ruxolitinib—LRRK2—brainstem—intracranial aneurysm	0.0065	0.0133	CbGeAlD
Ruxolitinib—JAK1—medulla oblongata—intracranial aneurysm	0.00611	0.0125	CbGeAlD
Ruxolitinib—DCLK1—medulla oblongata—intracranial aneurysm	0.00611	0.0125	CbGeAlD
Ruxolitinib—PRKG2—brain—intracranial aneurysm	0.00611	0.0125	CbGeAlD
Ruxolitinib—CAMK1D—medulla oblongata—intracranial aneurysm	0.00596	0.0122	CbGeAlD
Ruxolitinib—PHKG2—medulla oblongata—intracranial aneurysm	0.00593	0.0121	CbGeAlD
Ruxolitinib—DAPK2—medulla oblongata—intracranial aneurysm	0.00583	0.0119	CbGeAlD
Ruxolitinib—GRK1—brain—intracranial aneurysm	0.00583	0.0119	CbGeAlD
Ruxolitinib—PRKCE—brain—intracranial aneurysm	0.0057	0.0117	CbGeAlD
Ruxolitinib—JAK1—midbrain—intracranial aneurysm	0.00558	0.0114	CbGeAlD
Ruxolitinib—DCLK1—midbrain—intracranial aneurysm	0.00558	0.0114	CbGeAlD
Ruxolitinib—DAPK3—medulla oblongata—intracranial aneurysm	0.00548	0.0112	CbGeAlD
Ruxolitinib—PLK1—brain—intracranial aneurysm	0.00548	0.0112	CbGeAlD
Ruxolitinib—RPS6KA6—brain—intracranial aneurysm	0.00548	0.0112	CbGeAlD
Ruxolitinib—MAST1—brain—intracranial aneurysm	0.00548	0.0112	CbGeAlD
Ruxolitinib—DAPK2—midbrain—intracranial aneurysm	0.00533	0.0109	CbGeAlD
Ruxolitinib—CAMK1—cerebellum—intracranial aneurysm	0.00527	0.0108	CbGeAlD
Ruxolitinib—DCLK3—brain—intracranial aneurysm	0.00519	0.0106	CbGeAlD
Ruxolitinib—MARK2—cerebellum—intracranial aneurysm	0.00511	0.0105	CbGeAlD
Ruxolitinib—BMPR2—medulla oblongata—intracranial aneurysm	0.00511	0.0105	CbGeAlD
Ruxolitinib—DAPK3—midbrain—intracranial aneurysm	0.00501	0.0102	CbGeAlD
Ruxolitinib—TAOK2—cerebellum—intracranial aneurysm	0.00473	0.00968	CbGeAlD
Ruxolitinib—BMPR2—midbrain—intracranial aneurysm	0.00467	0.00956	CbGeAlD
Ruxolitinib—TAOK3—brainstem—intracranial aneurysm	0.00463	0.00948	CbGeAlD
Ruxolitinib—CAMK2G—medulla oblongata—intracranial aneurysm	0.00457	0.00936	CbGeAlD
Ruxolitinib—PLK3—brain—intracranial aneurysm	0.00457	0.00936	CbGeAlD
Ruxolitinib—LRRK2—medulla oblongata—intracranial aneurysm	0.00453	0.00928	CbGeAlD
Ruxolitinib—LTK—brain—intracranial aneurysm	0.00442	0.00904	CbGeAlD
Ruxolitinib—JAK3—cerebellum—intracranial aneurysm	0.00435	0.0089	CbGeAlD
Ruxolitinib—DCLK1—cerebellum—intracranial aneurysm	0.00432	0.00884	CbGeAlD
Ruxolitinib—JAK1—cerebellum—intracranial aneurysm	0.00432	0.00884	CbGeAlD
Ruxolitinib—CAMK1—brain—intracranial aneurysm	0.00428	0.00875	CbGeAlD
Ruxolitinib—CAMK1D—cerebellum—intracranial aneurysm	0.00422	0.00863	CbGeAlD
Ruxolitinib—PHKG2—cerebellum—intracranial aneurysm	0.00419	0.00858	CbGeAlD
Ruxolitinib—CAMK2G—midbrain—intracranial aneurysm	0.00418	0.00855	CbGeAlD
Ruxolitinib—BMP2K—midbrain—intracranial aneurysm	0.00418	0.00855	CbGeAlD
Ruxolitinib—MARK2—brain—intracranial aneurysm	0.00415	0.0085	CbGeAlD
Ruxolitinib—LRRK2—midbrain—intracranial aneurysm	0.00414	0.00848	CbGeAlD
Ruxolitinib—DAPK2—cerebellum—intracranial aneurysm	0.00412	0.00843	CbGeAlD
Ruxolitinib—MAP3K7—medulla oblongata—intracranial aneurysm	0.00411	0.00842	CbGeAlD
Ruxolitinib—STK16—cerebellum—intracranial aneurysm	0.00405	0.0083	CbGeAlD
Ruxolitinib—TYK2—medulla oblongata—intracranial aneurysm	0.00404	0.00827	CbGeAlD
Ruxolitinib—HIPK2—cerebellum—intracranial aneurysm	0.00403	0.00825	CbGeAlD
Ruxolitinib—MKNK2—medulla oblongata—intracranial aneurysm	0.00399	0.00816	CbGeAlD
Ruxolitinib—RET—medulla oblongata—intracranial aneurysm	0.00389	0.00796	CbGeAlD
Ruxolitinib—DAPK3—cerebellum—intracranial aneurysm	0.00387	0.00793	CbGeAlD
Ruxolitinib—TAOK2—brain—intracranial aneurysm	0.00384	0.00786	CbGeAlD
Ruxolitinib—CLK2—cerebellum—intracranial aneurysm	0.00384	0.00785	CbGeAlD
Ruxolitinib—MAP3K7—midbrain—intracranial aneurysm	0.00376	0.00769	CbGeAlD
Ruxolitinib—TYK2—midbrain—intracranial aneurysm	0.00369	0.00756	CbGeAlD
Ruxolitinib—JAK2—medulla oblongata—intracranial aneurysm	0.00368	0.00752	CbGeAlD
Ruxolitinib—MKNK2—midbrain—intracranial aneurysm	0.00364	0.00746	CbGeAlD
Ruxolitinib—IRAK1—midbrain—intracranial aneurysm	0.00364	0.00746	CbGeAlD
Ruxolitinib—DYRK1A—cerebellum—intracranial aneurysm	0.00363	0.00742	CbGeAlD
Ruxolitinib—BMPR2—cerebellum—intracranial aneurysm	0.00361	0.00739	CbGeAlD
Ruxolitinib—RET—midbrain—intracranial aneurysm	0.00355	0.00727	CbGeAlD
Ruxolitinib—MAP3K3—medulla oblongata—intracranial aneurysm	0.00354	0.00725	CbGeAlD
Ruxolitinib—JAK3—brain—intracranial aneurysm	0.00353	0.00723	CbGeAlD
Ruxolitinib—JAK1—brain—intracranial aneurysm	0.00351	0.00718	CbGeAlD
Ruxolitinib—DCLK1—brain—intracranial aneurysm	0.00351	0.00718	CbGeAlD
Ruxolitinib—PLK4—brain—intracranial aneurysm	0.00349	0.00714	CbGeAlD
Ruxolitinib—NUAK2—cerebellum—intracranial aneurysm	0.00345	0.00707	CbGeAlD
Ruxolitinib—CAMK1D—brain—intracranial aneurysm	0.00342	0.00701	CbGeAlD
Ruxolitinib—PHKG2—brain—intracranial aneurysm	0.0034	0.00697	CbGeAlD
Ruxolitinib—DAPK2—brain—intracranial aneurysm	0.00335	0.00685	CbGeAlD
Ruxolitinib—STK16—brain—intracranial aneurysm	0.00329	0.00674	CbGeAlD
Ruxolitinib—HIPK2—brain—intracranial aneurysm	0.00328	0.0067	CbGeAlD
Ruxolitinib—MAP3K3—midbrain—intracranial aneurysm	0.00324	0.00663	CbGeAlD
Ruxolitinib—BMP2K—cerebellum—intracranial aneurysm	0.00323	0.00662	CbGeAlD
Ruxolitinib—CAMK2G—cerebellum—intracranial aneurysm	0.00323	0.00662	CbGeAlD
Ruxolitinib—TAOK3—medulla oblongata—intracranial aneurysm	0.00323	0.00661	CbGeAlD
Ruxolitinib—MAP3K19—brain—intracranial aneurysm	0.00321	0.00657	CbGeAlD
Ruxolitinib—LRRK2—cerebellum—intracranial aneurysm	0.0032	0.00656	CbGeAlD
Ruxolitinib—DAPK3—brain—intracranial aneurysm	0.00315	0.00644	CbGeAlD
Ruxolitinib—CLK2—brain—intracranial aneurysm	0.00312	0.00638	CbGeAlD
Ruxolitinib—ROCK1—brain—intracranial aneurysm	0.00302	0.00618	CbGeAlD
Ruxolitinib—TAOK3—midbrain—intracranial aneurysm	0.00295	0.00604	CbGeAlD
Ruxolitinib—DYRK1A—brain—intracranial aneurysm	0.00295	0.00603	CbGeAlD
Ruxolitinib—MAP3K2—cerebellum—intracranial aneurysm	0.00294	0.00601	CbGeAlD
Ruxolitinib—BMPR2—brain—intracranial aneurysm	0.00294	0.00601	CbGeAlD
Ruxolitinib—MAP3K7—cerebellum—intracranial aneurysm	0.00291	0.00595	CbGeAlD
Ruxolitinib—TYK2—cerebellum—intracranial aneurysm	0.00286	0.00585	CbGeAlD
Ruxolitinib—MKNK2—cerebellum—intracranial aneurysm	0.00282	0.00577	CbGeAlD
Ruxolitinib—IRAK1—cerebellum—intracranial aneurysm	0.00282	0.00577	CbGeAlD
Ruxolitinib—NUAK2—brain—intracranial aneurysm	0.0028	0.00574	CbGeAlD
Ruxolitinib—RET—cerebellum—intracranial aneurysm	0.00275	0.00563	CbGeAlD
Ruxolitinib—CAMK2G—brain—intracranial aneurysm	0.00263	0.00538	CbGeAlD
Ruxolitinib—BMP2K—brain—intracranial aneurysm	0.00263	0.00538	CbGeAlD
Ruxolitinib—LRRK2—brain—intracranial aneurysm	0.0026	0.00533	CbGeAlD
Ruxolitinib—JAK2—cerebellum—intracranial aneurysm	0.0026	0.00532	CbGeAlD
Ruxolitinib—MAP3K3—cerebellum—intracranial aneurysm	0.0025	0.00513	CbGeAlD
Ruxolitinib—MAP3K2—brain—intracranial aneurysm	0.00239	0.00488	CbGeAlD
Ruxolitinib—MAP3K7—brain—intracranial aneurysm	0.00236	0.00484	CbGeAlD
Ruxolitinib—TYK2—brain—intracranial aneurysm	0.00232	0.00475	CbGeAlD
Ruxolitinib—MKNK2—brain—intracranial aneurysm	0.00229	0.00469	CbGeAlD
Ruxolitinib—IRAK1—brain—intracranial aneurysm	0.00229	0.00469	CbGeAlD
Ruxolitinib—TAOK3—cerebellum—intracranial aneurysm	0.00228	0.00467	CbGeAlD
Ruxolitinib—RET—brain—intracranial aneurysm	0.00223	0.00457	CbGeAlD
Ruxolitinib—JAK2—brain—intracranial aneurysm	0.00211	0.00432	CbGeAlD
Ruxolitinib—MAP3K3—brain—intracranial aneurysm	0.00203	0.00416	CbGeAlD
Ruxolitinib—TAOK3—brain—intracranial aneurysm	0.00185	0.0038	CbGeAlD
Ruxolitinib—JAK2—BDNF signaling pathway—NCF1—intracranial aneurysm	0.00109	0.00213	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Axon guidance—MMP2—intracranial aneurysm	0.00109	0.00213	CbGpPWpGaD
Ruxolitinib—JAK2—MyD88 cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.00108	0.0021	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—CTSK—intracranial aneurysm	0.00107	0.0021	CbGpPWpGaD
Ruxolitinib—JAK2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—intracranial aneurysm	0.00107	0.00209	CbGpPWpGaD
Ruxolitinib—TYK2—Toll Like Receptor 4 (TLR4) Cascade—AGER—intracranial aneurysm	0.00106	0.00208	CbGpPWpGaD
Ruxolitinib—MAP3K2—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.00105	0.00206	CbGpPWpGaD
Ruxolitinib—PRKCE—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.00105	0.00205	CbGpPWpGaD
Ruxolitinib—JAK2—MyD88 dependent cascade initiated on endosome—AGER—intracranial aneurysm	0.00105	0.00205	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—STARD13—intracranial aneurysm	0.00104	0.00204	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—SLC25A16—intracranial aneurysm	0.00103	0.00202	CbGpPWpGaD
Ruxolitinib—MAP3K7—Toll Like Receptor 4 (TLR4) Cascade—AGER—intracranial aneurysm	0.00103	0.00202	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—STARD13—intracranial aneurysm	0.00103	0.00201	CbGpPWpGaD
Ruxolitinib—JAK1—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.00102	0.002	CbGpPWpGaD
Ruxolitinib—JAK2—Toll Like Receptor 9 (TLR9) Cascade—AGER—intracranial aneurysm	0.00101	0.00198	CbGpPWpGaD
Ruxolitinib—ROCK1—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.00101	0.00197	CbGpPWpGaD
Ruxolitinib—JAK2—MyD88:Mal cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.000993	0.00194	CbGpPWpGaD
Ruxolitinib—TYK2—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000984	0.00192	CbGpPWpGaD
Ruxolitinib—IRAK1—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.000976	0.00191	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by VEGF—NOS3—intracranial aneurysm	0.000966	0.00189	CbGpPWpGaD
Ruxolitinib—CAMK2G—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.000959	0.00188	CbGpPWpGaD
Ruxolitinib—JAK2—Oncostatin M Signaling Pathway—CCL2—intracranial aneurysm	0.000957	0.00187	CbGpPWpGaD
Ruxolitinib—JAK2—MyD88-independent cascade—AGER—intracranial aneurysm	0.000953	0.00186	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by VEGF—NOS3—intracranial aneurysm	0.00095	0.00186	CbGpPWpGaD
Ruxolitinib—TYK2—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.000947	0.00185	CbGpPWpGaD
Ruxolitinib—JAK2—SHP2 signaling—NOS3—intracranial aneurysm	0.000934	0.00183	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—CST3—intracranial aneurysm	0.000929	0.00182	CbGpPWpGaD
Ruxolitinib—MAP3K7—TNF alpha Signaling Pathway—CCL2—intracranial aneurysm	0.000927	0.00181	CbGpPWpGaD
Ruxolitinib—MAP3K7—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.000919	0.0018	CbGpPWpGaD
Ruxolitinib—MAP3K3—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000905	0.00177	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—TIMP1—intracranial aneurysm	0.000902	0.00176	CbGpPWpGaD
Ruxolitinib—JAK2—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.000899	0.00176	CbGpPWpGaD
Ruxolitinib—ROCK1—EPH-Ephrin signaling—MMP9—intracranial aneurysm	0.000895	0.00175	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—CTSB—intracranial aneurysm	0.000887	0.00173	CbGpPWpGaD
Ruxolitinib—JAK2—Activated TLR4 signalling—AGER—intracranial aneurysm	0.000857	0.00168	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CTSS—intracranial aneurysm	0.000845	0.00165	CbGpPWpGaD
Ruxolitinib—JAK2—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.000842	0.00165	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—CST3—intracranial aneurysm	0.00084	0.00164	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Axon guidance—MMP9—intracranial aneurysm	0.000817	0.0016	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—NCF1—intracranial aneurysm	0.000808	0.00158	CbGpPWpGaD
Ruxolitinib—JAK2—Toll Like Receptor 4 (TLR4) Cascade—AGER—intracranial aneurysm	0.000806	0.00158	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—STARD13—intracranial aneurysm	0.000794	0.00155	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CTSK—intracranial aneurysm	0.000778	0.00152	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—MMP2—intracranial aneurysm	0.000776	0.00152	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—STARD13—intracranial aneurysm	0.000771	0.00151	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—SLC25A16—intracranial aneurysm	0.000763	0.00149	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—TIMP1—intracranial aneurysm	0.000761	0.00149	CbGpPWpGaD
Ruxolitinib—JAK2—Leptin signaling pathway—NOS3—intracranial aneurysm	0.00076	0.00149	CbGpPWpGaD
Ruxolitinib—TYK2—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000755	0.00148	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—STARD13—intracranial aneurysm	0.000748	0.00146	CbGpPWpGaD
Ruxolitinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.000746	0.00146	CbGpPWpGaD
Ruxolitinib—PRKG2—Hemostasis—NOS3—intracranial aneurysm	0.000736	0.00144	CbGpPWpGaD
Ruxolitinib—JAK1—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000734	0.00144	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—NCF1—intracranial aneurysm	0.000731	0.00143	CbGpPWpGaD
Ruxolitinib—ROCK1—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000722	0.00141	CbGpPWpGaD
Ruxolitinib—JAK2—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.000718	0.0014	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by VEGF—NOS3—intracranial aneurysm	0.000713	0.00139	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000711	0.00139	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CTSS—intracranial aneurysm	0.000678	0.00133	CbGpPWpGaD
Ruxolitinib—JAK2—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.000676	0.00132	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000658	0.00129	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—TIMP1—intracranial aneurysm	0.000655	0.00128	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CTSB—intracranial aneurysm	0.000644	0.00126	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CTSS—intracranial aneurysm	0.000643	0.00126	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CTSK—intracranial aneurysm	0.000624	0.00122	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CTSS—intracranial aneurysm	0.000624	0.00122	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CTSS—intracranial aneurysm	0.000621	0.00121	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CTSS—intracranial aneurysm	0.000607	0.00119	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CTSS—intracranial aneurysm	0.000605	0.00118	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—NCF1—intracranial aneurysm	0.000602	0.00118	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CTSK—intracranial aneurysm	0.000592	0.00116	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000585	0.00114	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—STARD13—intracranial aneurysm	0.000584	0.00114	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—MMP9—intracranial aneurysm	0.000583	0.00114	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CTSS—intracranial aneurysm	0.000581	0.00114	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SLC25A16—intracranial aneurysm	0.000578	0.00113	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CTSK—intracranial aneurysm	0.000574	0.00112	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—AGER—intracranial aneurysm	0.000573	0.00112	CbGpPWpGaD
Ruxolitinib—JAK2—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000572	0.00112	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CTSS—intracranial aneurysm	0.000572	0.00112	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CTSK—intracranial aneurysm	0.000572	0.00112	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000568	0.00111	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—NCF1—intracranial aneurysm	0.000566	0.00111	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CTSK—intracranial aneurysm	0.000558	0.00109	CbGpPWpGaD
Ruxolitinib—JAK2—CXCR4-mediated signaling events—MMP9—intracranial aneurysm	0.000557	0.00109	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CTSK—intracranial aneurysm	0.000557	0.00109	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—CST3—intracranial aneurysm	0.000546	0.00107	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by VEGF—NOS3—intracranial aneurysm	0.00054	0.00106	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CTSK—intracranial aneurysm	0.000535	0.00105	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000534	0.00105	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000531	0.00104	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CTSK—intracranial aneurysm	0.000527	0.00103	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CTSB—intracranial aneurysm	0.000517	0.00101	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—NCF1—intracranial aneurysm	0.000514	0.00101	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—NCF1—intracranial aneurysm	0.000512	0.001	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000494	0.000965	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CTSS—intracranial aneurysm	0.000492	0.000963	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CTSB—intracranial aneurysm	0.00049	0.000958	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000486	0.00095	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000483	0.000945	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CTSB—intracranial aneurysm	0.000475	0.00093	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—NCF1—intracranial aneurysm	0.000474	0.000928	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CTSB—intracranial aneurysm	0.000473	0.000925	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CTSS—intracranial aneurysm	0.000473	0.000925	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—NCF1—intracranial aneurysm	0.000471	0.000921	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CTSB—intracranial aneurysm	0.000462	0.000904	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CTSB—intracranial aneurysm	0.000461	0.000902	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—NCF1—intracranial aneurysm	0.00046	0.000899	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CTSK—intracranial aneurysm	0.000453	0.000886	CbGpPWpGaD
Ruxolitinib—JAK1—Axon guidance—MMP2—intracranial aneurysm	0.00045	0.00088	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000448	0.000877	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CTSB—intracranial aneurysm	0.000443	0.000866	CbGpPWpGaD
Ruxolitinib—ROCK1—Axon guidance—MMP2—intracranial aneurysm	0.000443	0.000866	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—NCF1—intracranial aneurysm	0.00044	0.000861	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CTSB—intracranial aneurysm	0.000436	0.000853	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CTSK—intracranial aneurysm	0.000435	0.000851	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—NCF1—intracranial aneurysm	0.000434	0.000848	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000425	0.000831	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000418	0.000817	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—AGER—intracranial aneurysm	0.000416	0.000813	CbGpPWpGaD
Ruxolitinib—JAK2—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000411	0.000803	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—NOS3—intracranial aneurysm	0.000407	0.000795	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CST3—intracranial aneurysm	0.000396	0.000775	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000386	0.000754	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000379	0.000742	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CTSB—intracranial aneurysm	0.000375	0.000733	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CTSS—intracranial aneurysm	0.000374	0.000732	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—NCF1—intracranial aneurysm	0.000373	0.00073	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000368	0.00072	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TIMP1—intracranial aneurysm	0.000366	0.000717	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CTSS—intracranial aneurysm	0.000363	0.000711	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CTSB—intracranial aneurysm	0.00036	0.000705	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CTSS—intracranial aneurysm	0.000353	0.000689	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CTSK—intracranial aneurysm	0.000345	0.000674	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—NCF1—intracranial aneurysm	0.000344	0.000674	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—NOS3—intracranial aneurysm	0.000343	0.000671	CbGpPWpGaD
Ruxolitinib—JAK1—Axon guidance—MMP9—intracranial aneurysm	0.000338	0.000662	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—NOS3—intracranial aneurysm	0.000335	0.000656	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CTSK—intracranial aneurysm	0.000334	0.000654	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—AGER—intracranial aneurysm	0.000333	0.000652	CbGpPWpGaD
Ruxolitinib—ROCK1—Axon guidance—MMP9—intracranial aneurysm	0.000333	0.000651	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NCF1—intracranial aneurysm	0.000332	0.00065	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—MMP2—intracranial aneurysm	0.000332	0.00065	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CTSK—intracranial aneurysm	0.000324	0.000634	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—MMP2—intracranial aneurysm	0.000321	0.000628	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—AGER—intracranial aneurysm	0.000316	0.000618	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—MMP2—intracranial aneurysm	0.000316	0.000618	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—EDNRA—intracranial aneurysm	0.000314	0.000614	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—AGER—intracranial aneurysm	0.000307	0.0006	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—AGER—intracranial aneurysm	0.000305	0.000597	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—NOS3—intracranial aneurysm	0.000303	0.000593	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—NOS3—intracranial aneurysm	0.000299	0.000584	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—AGER—intracranial aneurysm	0.000298	0.000583	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—AGER—intracranial aneurysm	0.000298	0.000582	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—NOS3—intracranial aneurysm	0.000295	0.000577	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CST3—intracranial aneurysm	0.000292	0.000572	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CTSB—intracranial aneurysm	0.000285	0.000558	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000285	0.000557	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—NCF1—intracranial aneurysm	0.000284	0.000555	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—AGER—intracranial aneurysm	0.000281	0.00055	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NCF1—intracranial aneurysm	0.00028	0.000548	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—CCL2—intracranial aneurysm	0.00028	0.000548	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CTSB—intracranial aneurysm	0.000277	0.000541	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CTSS—intracranial aneurysm	0.000275	0.000539	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—NCF1—intracranial aneurysm	0.000275	0.000539	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CTSB—intracranial aneurysm	0.000269	0.000525	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—NCF1—intracranial aneurysm	0.000267	0.000522	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—EDNRA—intracranial aneurysm	0.000265	0.000518	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—CCL2—intracranial aneurysm	0.000263	0.000515	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—CCL2—intracranial aneurysm	0.000262	0.000512	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NCF1—intracranial aneurysm	0.000254	0.000497	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—NOS3—intracranial aneurysm	0.000254	0.000496	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CTSK—intracranial aneurysm	0.000253	0.000496	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—MMP2—intracranial aneurysm	0.000252	0.000492	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—MMP9—intracranial aneurysm	0.00025	0.000488	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—NOS3—intracranial aneurysm	0.00025	0.000488	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—AGER—intracranial aneurysm	0.000242	0.000473	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—MMP9—intracranial aneurysm	0.000241	0.000472	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NCF1—intracranial aneurysm	0.000241	0.000472	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—CCL2—intracranial aneurysm	0.000238	0.000466	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000238	0.000465	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—MMP9—intracranial aneurysm	0.000237	0.000464	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NCF1—intracranial aneurysm	0.000237	0.000464	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—MMP2—intracranial aneurysm	0.000237	0.000464	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—NOS3—intracranial aneurysm	0.000235	0.000459	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—AGER—intracranial aneurysm	0.000233	0.000455	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000228	0.000446	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000224	0.000438	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CST3—intracranial aneurysm	0.000222	0.000433	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—CCL2—intracranial aneurysm	0.000221	0.000432	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000216	0.000422	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—NOS3—intracranial aneurysm	0.000212	0.000415	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CTSB—intracranial aneurysm	0.00021	0.00041	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NCF1—intracranial aneurysm	0.000209	0.000408	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—MMP9—intracranial aneurysm	0.0002	0.000392	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—NOS3—intracranial aneurysm	0.000197	0.000385	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NCF1—intracranial aneurysm	0.000193	0.000377	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—CCL2—intracranial aneurysm	0.00019	0.000372	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—MMP9—intracranial aneurysm	0.000189	0.00037	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—MMP9—intracranial aneurysm	0.000188	0.000368	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—CCL2—intracranial aneurysm	0.000187	0.000366	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—AGER—intracranial aneurysm	0.000184	0.00036	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NCF1—intracranial aneurysm	0.000183	0.000359	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MMP2—intracranial aneurysm	0.00018	0.000351	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—AGER—intracranial aneurysm	0.000179	0.00035	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—MMP9—intracranial aneurysm	0.000178	0.000348	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NCF1—intracranial aneurysm	0.000178	0.000348	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—AGER—intracranial aneurysm	0.000173	0.000339	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000173	0.000339	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NCF1—intracranial aneurysm	0.000173	0.000338	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—MMP9—intracranial aneurysm	0.00017	0.000333	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000168	0.000329	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—NOS3—intracranial aneurysm	0.000165	0.000323	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—EDNRA—intracranial aneurysm	0.000163	0.000319	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CCL2—intracranial aneurysm	0.000155	0.000302	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—NOS3—intracranial aneurysm	0.000143	0.000279	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CCL2—intracranial aneurysm	0.00014	0.000274	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NOS3—intracranial aneurysm	0.000138	0.00027	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000137	0.000268	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—AGER—intracranial aneurysm	0.000135	0.000265	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MMP9—intracranial aneurysm	0.000135	0.000264	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NCF1—intracranial aneurysm	0.000135	0.000264	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CCL2—intracranial aneurysm	0.00013	0.000255	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000127	0.000249	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NOS3—intracranial aneurysm	0.000116	0.000227	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CCL2—intracranial aneurysm	0.000112	0.00022	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MMP9—intracranial aneurysm	0.000111	0.000216	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CCL2—intracranial aneurysm	0.00011	0.000216	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCL2—intracranial aneurysm	0.000106	0.000208	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS3—intracranial aneurysm	0.000105	0.000206	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NOS3—intracranial aneurysm	0.0001	0.000196	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NOS3—intracranial aneurysm	9.84e-05	0.000192	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MMP9—intracranial aneurysm	9.33e-05	0.000182	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	9.07e-05	0.000177	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCL2—intracranial aneurysm	8.54e-05	0.000167	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCL2—intracranial aneurysm	8.29e-05	0.000162	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCL2—intracranial aneurysm	8.04e-05	0.000157	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MMP9—intracranial aneurysm	8.03e-05	0.000157	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS3—intracranial aneurysm	7.99e-05	0.000156	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MMP9—intracranial aneurysm	7.9e-05	0.000154	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOS3—intracranial aneurysm	7.61e-05	0.000149	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOS3—intracranial aneurysm	7.39e-05	0.000144	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOS3—intracranial aneurysm	7.16e-05	0.00014	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL2—intracranial aneurysm	6.28e-05	0.000123	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP9—intracranial aneurysm	6.1e-05	0.000119	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP9—intracranial aneurysm	5.93e-05	0.000116	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP9—intracranial aneurysm	5.75e-05	0.000112	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOS3—intracranial aneurysm	5.6e-05	0.000109	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP9—intracranial aneurysm	4.49e-05	8.78e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NOS3—intracranial aneurysm	1.89e-05	3.7e-05	CbGpPWpGaD
